Uncovering the Truth: AI Company Accused of Fraud in $6 Million NFT Scam

Youtuber Exposes AI Company Rabbit’s NFT Scam The Rabbit NFT Scam Unveiled Youtuber and internet investigator Coffeezilla has recently stirred up controversy by calling out Artificial Intelligence (AI) company Rabbit for allegedly being involved in a $6 million non-fungible token (NFT) scam. The company is being accused of orchestrating the GAMA NFT Project “fraud,” adding…

Read More

Rohde & Schwarz and Ceva Unveil Groundbreaking Bluetooth OTA Test Solution: A Game-Changer in Wireless Technology!

Get Ready for the Next Big Thing in Bluetooth®: Unified Test Protocol (UTP) Test Mode The world of wireless technology is always evolving, and Bluetooth® is no exception. With the next release of Bluetooth® on the horizon, there’s an exciting new feature that’s sure to make a splash: the Unified Test Protocol (UTP) Test Mode…

Read More

“AMC Networks Falls Short: Q4 Earnings and Revenue Disappoint Estimates”

AMC Networks Quarterly Earnings Disappoint Investors Quarterly Earnings Fall Short AMC Networks (AMCX) recently reported their quarterly earnings, coming in at $0.64 per share. This figure fell short of the Zacks Consensus Estimate of $0.79 per share, disappointing investors. The company’s earnings also declined from $0.72 per share compared to the same quarter last year….

Read More

Travere Therapeutics Prepares to Submit pivotal SNDA for FILSPARI (sparsentan) in the Treatment of FSGS

Travere Therapeutics Announces Plans to Seek Traditional Approval of FILSPARI for Focal Segmental Glomerulosclerosis Travere Therapeutics, a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with rare diseases, recently announced that it has completed a Type C meeting with the U.S. Food and Drug Administration (FDA) regarding its plan to…

Read More